arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

download Export Data

INTELLIGENT BIO SOLUTIONS INC.

INBS

$1.77 ▼ -0.05 (-2.75%) at close

8 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

INTELLIGENT BIO SOLUTIONS INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.6M

Dividend Yield —

Revenue Growth 38.1% ↗

Op. Margin -299.1% ↗

ROIC -180.7% ↗

FCF / Share $-8.18 ↘

Trailing P/E —

Price / Book 0.9x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

8-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$4.22M

↑ +38.1% —

Net Income Profit after all expenses

$-12.43M

↓ -17.6% —

Operating Margin Operating profit as % of sales

-299.1%

↑ +14.2% 0th

FCF / Share Free cash flow per share

$-8.18

↓ -335.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 10-K ↗	FY 2021 Jun 30, 2021 10-K ↗	FY 2020 Jun 30, 2020 10-K ↗	FY 2019 Jun 30, 2019 10-K ↗
Revenue Growth YoY (%)	38.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+376%)	-1.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-124%)	147.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1745%)	187.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2244%)	-77.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1074%)	949.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11766%)	—	—
EPS Growth YoY (%)	-322.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	68.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	39.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-1756.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	16.2% Good Good Year-over-year change in earnings per share Optimal: > 10%	—	—	—
Net Income Growth YoY (%)	-17.6% Weak ↓ Weak Declining Year-over-year change in net income	-4.1% Weak ↑ Weak Improving Year-over-year change in net income	4.5% Caution ↑ Caution Improving Year-over-year change in net income	-28.0% Weak ↑ Weak Improving Year-over-year change in net income	-18.0% Weak Weak Year-over-year change in net income	-122.4% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-335.6% Weak ↑ Weak Improving Year-over-year change in free cash flow	69.4% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	16.3% Good ↑ Good Improving Year-over-year change in free cash flow	-3107.1% Weak Weak Year-over-year change in free cash flow	78.9% Excellent Excellent Year-over-year change in free cash flow	—	—	—
Revenue CAGR 3Y (%)	49.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	91.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	16.3% Excellent Excellent Compound annual revenue growth over 3 years	88.1% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	16.3% Excellent Excellent Compound annual revenue growth over 5 years	74.5% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 10-K ↗	FY 2021 Jun 30, 2021 10-K ↗	FY 2020 Jun 30, 2020 10-K ↗	FY 2019 Jun 30, 2019 10-K ↗
Operating Margin (%) (%)	-299.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2094%)	-348.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2425%)	-330.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2303%)	—	—	-281.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1976%)	—	—
Profit Margin (%) (%)	-294.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2558%)	-346.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2985%)	-326.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2820%)	—	—	-355.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3061%)	—	—
FCF Margin (%) (%)	-285.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-324.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-314.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	-264.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.61x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.16x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 10-K ↗	FY 2021 Jun 30, 2021 10-K ↗	FY 2020 Jun 30, 2020 10-K ↗	FY 2019 Jun 30, 2019 10-K ↗
Return on Invested Capital (%)	-180.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-280.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-81.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-261.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-99.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	43.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-105.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-129.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-74.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-121.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-67.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-25.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-115.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-225.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1604%)	—	-121.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-913%)	-279.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1966%)	-125.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-936%)	-46.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-412%)	61.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+307%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 10-K ↗	FY 2021 Jun 30, 2021 10-K ↗	FY 2020 Jun 30, 2020 10-K ↗	FY 2019 Jun 30, 2019 10-K ↗
Debt to Equity (x)	—	—	0.20x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-67%)	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	-30.08x Weak Weak Operating income divided by interest expense Optimal: > 5x	-8.73x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-3.99M	$-1.02M	$-4.65M	$-1.54M	$-8.24M	$-12.57M	$-427.27K	—
Debt / EBITDA (x)	—	—	-0.18x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 10-K ↗	FY 2021 Jun 30, 2021 10-K ↗	FY 2020 Jun 30, 2020 10-K ↗	FY 2019 Jun 30, 2019 10-K ↗
Revenue per Share (USD)	$2.86	$0.58	$1.95	$1.25	$0.03	$0.19	—	—
Basic EPS, GAAP (USD)	$-8.44	$-2.00	$-6.38	$-10.58	$-0.57	$-0.68	—	—
Free Cash Flow per Share (USD)	$-8.18	$-1.88	$-6.15	$-7.34	$-0.23	$-1.08	—	—
Book Value per Share (USD)	$1.90	$0.41	$2.41	$1.63	$0.44	$1.11	$-0.60	—
Tangible Book Value per Share (USD)	$0.93	$-0.11	$1.15	$-2.26	$0.44	$1.11	$-0.60	—
Basic Weighted Avg Shares (shares)	1.47M	5.27M	1.59M	1.00M	14.67M	10.41M	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 10-K ↗	FY 2021 Jun 30, 2021 10-K ↗	FY 2020 Jun 30, 2020 10-K ↗	FY 2019 Jun 30, 2019 10-K ↗
Working Capital (USD)	$2.17M	$-1.21M	$3.08M	$-2.02M	$6.20M	$14.52M	$-5.35M	—
LT Debt (USD)	—	—	$1.65M	—	—	—	—	—
Total Equity (USD)	$5.51M	$3.00M	$8.33M	$3.80M	$6.62M	$15.06M	$-5.19M	$-3.98M

📋 What is driving earnings? 4 metrics

Metric	FY 2026 Jun 30, 2026 10-K ↗	FY 2025 Jun 30, 2025 10-K ↗	FY 2024 Jun 30, 2024 10-K ↗	FY 2023 Jun 30, 2023 10-K ↗	FY 2022 Jun 30, 2022 10-K ↗	FY 2021 Jun 30, 2021 10-K ↗	FY 2020 Jun 30, 2020 10-K ↗	FY 2019 Jun 30, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$4.22M	$3.05M	$3.11M	$1.26M	$437.15K	$1.98M	$188.74K	—
Depreciation Expense (USD)	$68.33K	$970.12K	$974.36K	$814.48K	—	—	—	—
Net Income, GAAP (USD)	$-12.43M	$-10.57M	$-10.16M	$-10.63M	$-8.31M	$-7.04M	$-3.16M	—
Operating Cash Flow (USD)	$-11.93M	$-9.68M	$-9.57M	$-7.38M	$-3.36M	$-11.30M	$-498.62K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 8 years · 28 quarters

INTELLIGENT BIO SOLUTIONS INC.

Analytical Summary

8-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare INBS with peers